I noticed the same point. Practically this increases the statistical significance. Decreasing the chance that PAA was just lucky with the patients it recruited and increasing the probability that Monepantel is an effective treatment. Highly overlooked by the market at this stage.
Ann: Positive Interim Study Results from OLE Study in ALS, page-32
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $94.89M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.5¢ | $32.55K | 166.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 248409 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 98968 | 3 |
View Market Depth
| Last trade - 12.09pm 03/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |